Completed Materials & Manufacturing

Tucana

Funder UKRI
Recipient organisation Jaguar Land Rover Limited
Funding £9.7M
Period Nov 2018 — Oct 2021

About this grant

This summary is based on the grant title only — the full abstract was not available.

No substantive source abstract was published for this research project funded by UKRI.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

Tucana 17855 - CCP Gransden Continuity
Tucan
HER2CLIMB - Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
TACE-3: A two-arm multi-stage (TAMS) seamless phase II/III randomised trial of nivolumab in combination with TACE for patients with intermediate stage HCC

Original classification

BEIS-Funded Programmes

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.